申请人:Lindsley W. Craig
公开号:US20070105902A1
公开(公告)日:2007-05-10
The present invention is directed to compounds that inhibit the glycine transporter GlyT1 and which are useful in the treatment of neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction and diseases in which the glycine transporter GlyT1 is involved.
本发明涉及抑制甘氨酸转运体GlyT1的化合物,这些化合物对于治疗与甘氨酸能或谷氨酸能神经递质功能障碍相关的神经和精神障碍以及涉及甘氨酸转运体GlyT1的疾病是有用的。